These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21933605)
21. Re: acute onycholysis during chemotherapy with doxetaxel (taxotere). Rall S; Lohmeyer JA; Machens HG; Mailänder P J Hand Surg Eur Vol; 2008 Apr; 33(2):214-5. PubMed ID: 18443069 [No Abstract] [Full Text] [Related]
22. Photosensitive rash in association with porphyrin biosynthesis possibly induced by docetaxel and trastuzumab therapy in a patient with metastatic breast carcinoma. Akay BN; Unlu E; Buyukcelik A; Akyol A Jpn J Clin Oncol; 2010 Oct; 40(10):989-91. PubMed ID: 20522447 [TBL] [Abstract][Full Text] [Related]
23. Nail toxicity induced by cancer chemotherapy. Gilbar P; Hain A; Peereboom VM J Oncol Pharm Pract; 2009 Sep; 15(3):143-55. PubMed ID: 19171552 [TBL] [Abstract][Full Text] [Related]
24. Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer. Kaya AO; Buyukberber S; Coskun U; Yildiz R; Ozturk B; Yaman E; Adisen E; Gureli M; Benekli M Cutan Ocul Toxicol; 2008; 27(4):327-31. PubMed ID: 18828046 [TBL] [Abstract][Full Text] [Related]
25. Severe nail changes due to Docetaxel treatment. Rafi L; Friedrich M; Tilgen W; Reichrath J Eur J Dermatol; 2003; 13(6):610-1. PubMed ID: 14721789 [TBL] [Abstract][Full Text] [Related]
27. Nail disease in psoriatic arthritis: distal phalangeal bone edema detected by magnetic resonance imaging predicts development of onycholysis and hyperkeratosis. Dalbeth N; Pui K; Lobo M; Doyle A; Jones PB; Taylor WJ; McQueen FM J Rheumatol; 2012 Apr; 39(4):841-3. PubMed ID: 22337245 [TBL] [Abstract][Full Text] [Related]
28. Medical Pearl: Docetaxel-induced onycholysis. Tinio P; Bershad S; Levitt JO J Am Acad Dermatol; 2005 Feb; 52(2):350-1. PubMed ID: 15692485 [No Abstract] [Full Text] [Related]
30. Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial. Mazzega-Fabbro C; Polesel J; Spazzapan S; Meneghetti L; Montagner D; Tabaro G; Bartoletti M; Puglisi F Clin Breast Cancer; 2023 Jun; 23(4):447-453. PubMed ID: 36997403 [TBL] [Abstract][Full Text] [Related]
32. Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I study. Pronk LC; Schrijvers D; Schellens JH; de Bruijn EA; Planting AS; Locci-Tonelli D; Groult V; Verweij J; van Oosterom AT Semin Oncol; 1998 Feb; 25(1 Suppl 2):23-8. PubMed ID: 9535208 [TBL] [Abstract][Full Text] [Related]
33. Common nail disorders. Shemer A; Daniel CR Clin Dermatol; 2013; 31(5):578-86. PubMed ID: 24079587 [TBL] [Abstract][Full Text] [Related]
34. A randomised controlled trial of interventions for taxane-induced nail toxicity in women with early breast cancer. Morrison A; Marshall-McKenna R; McFadyen AK; Hutchison C; Rice AM; Stirling L; McIlroy P; Macpherson IR Sci Rep; 2022 Jul; 12(1):11575. PubMed ID: 35798751 [TBL] [Abstract][Full Text] [Related]